Zealand Pharma CEO hopes for partnership news in coming months

CEO Adam Steensberg is hoping to soon have more to say about new strategic partners concerning product sales going forward.

Photo: Zealand Pharma

Zealand Pharma, a biotech firm publicly listed in Denmark, has been undergoing comprehensive structural changes since March.

Back then, the firm announced that future product sales, as well as late-stage programs, would happen with the help of strategic partnerships going forward. Changing things up at Zealand Pharma also meant that the firm initiated a 90% reduction to its workforce in the US – and in its home country of Denmark, staffing was also cut.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs